Growing community of inventors

Chicago, IL, United States of America

Edward K Pabich

Average Co-Inventor Count = 3.98

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 397

Edward K PabichRonald L Marshall (6 patents)Edward K PabichJohn J Carrino (4 patents)Edward K PabichJohn A Salituro (3 patents)Edward K PabichHong Yu (3 patents)Edward K PabichMatthew T Manlove (3 patents)Edward K PabichJohn D Burczak (3 patents)Edward K PabichPaul A Klonowski (3 patents)Edward K PabichOmar S Khalil (1 patent)Edward K PabichStanley R Bouma (1 patent)Edward K PabichUwe Spies (1 patent)Edward K PabichLaurie A Rinehardt (1 patent)Edward K PabichEdward K Pabich (8 patents)Ronald L MarshallRonald L Marshall (13 patents)John J CarrinoJohn J Carrino (26 patents)John A SalituroJohn A Salituro (13 patents)Hong YuHong Yu (9 patents)Matthew T ManloveMatthew T Manlove (5 patents)John D BurczakJohn D Burczak (4 patents)Paul A KlonowskiPaul A Klonowski (3 patents)Omar S KhalilOmar S Khalil (26 patents)Stanley R BoumaStanley R Bouma (12 patents)Uwe SpiesUwe Spies (3 patents)Laurie A RinehardtLaurie A Rinehardt (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Abbott Laboratories Corporation (6 from 4,177 patents)

2. Other (1 from 832,680 patents)

3. Abbott Molecular Inc. (1 from 96 patents)


8 patents:

1. 9187789 - Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae

2. 8580495 - [object Object]

3. 7807802 - [object Object]

4. 5846785 - Oligonucleotides specific for the MOMP gene sequence and methods for the

5. 5756298 - Oligonucleotides and methods for the detection of Chlamydia trachomatis

6. 5601978 - Oligonucleotides and methods for the detection of chlamydia trachomatis

7. 5585242 - Method for detection of nucleic acid using total internal reflectance

8. 5573907 - Detecting and amplifying target nucleic acids using exonucleolytic

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…